dipyridamole has been researched along with EHS Tumor in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gastpar, H | 1 |
| Schmähl, D | 1 |
| Höllenriegel, K | 1 |
| Mundt, D | 1 |
1 review available for dipyridamole and EHS Tumor
| Article | Year |
|---|---|
[The inhibition of cancer cell stickiness by pyrimido-pyrimidine derivatives].
Topics: Animals; Cell Adhesion; Dipyridamole; Dose-Response Relationship, Drug; Mesentery; Molecular Conform | 1973 |
1 other study available for dipyridamole and EHS Tumor
| Article | Year |
|---|---|
[Investigations in multi-step-therapy of cancer (according to M. v. Ardenne) in animal experiments (author's transl)].
Topics: Animals; Ascorbic Acid; Benzopyrenes; Carcinoma; Carcinoma, Ehrlich Tumor; Dipyridamole; Female; Glu | 1974 |